EZH2 and cancer: Additionally, the histone methyltransferase EZH2 was overexpressed in endometrial cancer cells, and knockdown of EZH2 expression as well as treatment with an EZH2-selective inhibitor resulted in cancer growth suppression and apoptosis [11].